Magvation makes operating rooms smarter & safer via disruptive Medtech innovations that mitigate human errors & ameliorate surgical system errors’ root cause — elevating standard-of-care. Magvation is in the business of profitably saving lives by precluding & ameliorating the 3rd leading cause of death in the United States – avoidable adverse events resulting from preventable human errors & system-design flaws.Jason leads a galvanized alliance of business & healthcare luminaries mined from the industry’s finest sources and forged in fiery start-up crucibles. Jason's team comprises proven executives who have worked together numerous times over the past 16 years, CEOs for multiple corporations, senior sales executives for leading healthcare companies, and running major integrated health systems. Jason's team truly understands that for Magvation to achieve a prolific financial and societal return on investment requires unwavering dedication, accountable execution, and an unyielding passion for saving lives & money!

Charter member of CEO Advisory Board

DON'T PICK UP THIS BOOK UNLESS you aspire to; investigate like Sherlock Holmes, question like Lt. Columbo, diagnose like Dr. House, empathize like Dr. Phill, think like Da Vinci, and commit like Winston Churchill.PUT THIS BOOK DOWN ULESS you're passionate about; being told no, no, and more no, challenging the status quo, creating and capturing real value, inspiring with vision and educating with insight, helping people with their issues and successes, and making the kind of money that enables dynamic life choices. OK, if you're still holding this book, then you at least have the obligatory aspiration and passion for sales. But do you also possess the inherent EQ to influence change through "storied human connections", and the requisite "Challenger" qualities to teach, tailor, and take control. Because to become an "Initiator" and sell disruptive innovations you must. It's like selling high-tech tunicates to customers who don't know why, or how badly they're bleeding, much less even know what a tourniquet is!READ ON IF you think you might have what it takes, because within these pages you have the disruptive paradigm - hardened by missionary market fire and baptized by FORTUNE 500 brimstone - for "selling change" that will positively disrupt your way of thinking! READ IT AGAIN and again. Because you will not only embrace why Fear & Fame are at the heart of every decision to 'change and buy', but you'll also become unconsciously competent at:* How to recognize a truly disruptive innovation* Why ‘solution selling’ is so yesterday* What makes a disruptive innovation sale different than any other* How to be an “Initiator Sales Campaign Director" * How to use Campaigner Based Selling and CATALYTIC SALES* Who are the same Stakeholders in every deal, at every company, every time* How to Investigate Fear & Inspire Fame* How to keep a prospect from getting the SHITS* How to make the Campaigner Based Selling System part of your company and part of your life

"I help fellow Selling CEOs stone-proof their glass houses"As CEOs, our lives are quite observable; our careers are relatively fragile; and our ill-advised decisions are typically visible. Consequently, bad advice is all too often just like a thrown stone. My stone-proofing takes the form of a remarkable group of confidential CEO peer-advisors."By assembling high-performing & critically-thinking CEOs, who are all committed to resolving each others critical business & personal issues, and uncovering veiled opportunities, our risk of bad advice is mitigated - and the potential for disruptive innovation is astonishing! The Disruptive Innovation Advisory Board (DIAB) assists its members cultivate predictable and repeatable strategies for introducing disruptive technology into new and emerging markets. The group dynamics are carefully orchestrated to facilitate conditional issue-resolution and value-creation, particular to companies that disrupt market paradigms. The DIAB is purpose-built, so that each CEO brings a unique set of skills, perspectives, and insights - creating powerful synergy. Through a combination of custom programs, proprietary systems, small group interchange, individualized coaching, and advanced networking, the DIAB is designed to accelerate its member's career and personal growth - as well as promote the advancement of their disruptive technology. By leveraging the power of open and honest confidential structured-dialog, the DIABs transformative format encourages and stimulates critical-thinking and critical-feedback amongst the group. And by viewing issues through objective peer-lenses, group members are uniquely positioned to candidly give, and safely receive, 'good advice' on anything from hostile board members - to hostile takeovers. So, not only does each member improve their individual performance, they also guide their peers - giving back some of the wisdom bestowed onto them throughout their successful lives and careers!

For 10 years Howe served as CEO of CBS2, a visionary executive level advisory and consulting firm focused on helping clients develop predictable and repeatable strategies for introducing disruptive technology into new & emerging markets, in the areas of: Applied Health Technology, Biotechnology, B2B Hospital Services, Health Data Compliance Health Information Systems, Integrated Healthcare Delivery, Medical Devices, and RTLS/RFID/GPS.Now Chairman, Howe inspires clients to transform their systems of market entry & revenue generation from a conventional solution-selling modality into a disruptive innovation value-capture archetype. CBS Squared developed and employs CATALYTIC SALES, The CBS-System, Value-Capture Forecast, IMPACT Questioning, and the Initiator Compensation. CBS2 (Squared) Raises Sales to the Power of Two"Using a 'solution sales' approach for selling disruptive innovations is like trying to fit a square peg into a round hole - it doesn't work for the peg or the hole!"This idiomatic quotation can be applied to the sales & marketing strategies of so many disruptive innovation companies. In fact, empirical findings indicate that over 96% of all disruptive technology company’s sales and marketing stratagems are inherently misaligned with their target customer’s disruptive value-creation paradigms. (P >.05%, n=1323) Which is one of the main reasons why so many companies with great technologies so often fail.“Disruptive innovations face competition from the formidable inertia powering the status quo. Success therefore comes from taking on the only three real competitors every innovator must understand and overcome: The way it is done, the way it should be done, and the best way to get it done. The startup world is littered with the fossils of companies that developed superior technologies and failed to sell it. Selling breakout products requires both Buyers AND Sellers to disrupt their status quo. So disrupt - or fail. There is no middle ground.”

Howe was appointed President & CEO of Vaporstream, the only truly record-less digital messaging platform. Howe was responsible for driving the company's growth and profitability and executing its mission; to deliver solutions that provide organizations in the enterprise and healthcare market with a universal recordless platform for safe, ESI-Statue compliant, digital communications. Howe served as 'Chief Sales Guy' and managed all aspects of company business, with an emphasis on business development and marketing. Howe successfully led the company to its next stage of evolution. Howe also served on the Board of Directors.

Howe was appointed CEO & Board Director of BioVigil, a healthcare hygiene compliance company. Howe lead US & international commercialization and expansion efforts, and drove the company's growth and profitability by executing its mission: To deliver solutions that reduce healthcare-associated infections though enhanced hand-washing compliance for enterprise and systems healthcare clients. Howe managed all aspects of company business with and emphasis on pilot customer acquisition and Series A Fundraising, where he successfully entered the company into 3 POCs and completed a $4M raise of outside venture capital.

Howe was appointed CEO & Board Director of Awarepoint, a novel RFID technology company targeting the acute-care & long-term care markets. Howe led the company to become the largest provider of Real Time Location Solutions (RTLS) for major healthcare systems & integrated delivery networks. Howe grew the company from $250K in annual revenue to over $23M, took the company from $3M to more than $87M in market valuation - all in less than three years. Howe helped raise over $26M in net-new venture funding and was instrumental in making Awarepoint one of Modern Healthcare Magazine’s “Top 100 Places to Work in Healthcare” from 2008 to 2010 (Rank 7th & 8th).

Contracted as the SVP of sales and business development, and became the interim CEO of Federation Software. Howe was responsible for the sales and marketing of a fully managed intellectual property supply chain management software designed to federate critical information for remote healthcare facilities and military contractors. Howe facilitated the sale of the company to Lockheed Martin.

Howe served as the SVP of Sales and Professional Services at CreekPath Systems, a revolutionary Storage Resource Management (SRM) company targeting Fortune 500 enterprise companies and system healthcare organizations. Howe was responsible for all aspects of go-to-market strategy, staffing, compensation, forecasting, account planning, deal-negotiation and personnel development for direct, channel, and OEM sales. Howe successfully took annual revenue from less than $1M to over $13.8M in less than two years and helped position the company for a strategic acquisition by Opsware.

Howe served as the SVP of Sales & Business Development for Edgix Corporation, a novel content distribution & satellite communications company targeting MTUs, CELECs, and IDN's. Howe, coordinated the initial product launch and led sales, marketing and business development efforts for global markets. Helped facilitate $72M in venture funding and generated over $38M in billable revenue. Instrumental in the Merger & Acquisition of Edgix / Unibex with FDC.

Howe served as the AVP of Enterprise & Healthcare Technology Sales of PTC, a CAD/CAM/LCM solutions provider targeting discreet manufacturing and the medical device industry. Howe led sales efforts for the Rockies Region for Fortune 1000 Enterprises and Medical Device Manufactures.

As the president and founder of Medical Dynamics, a minimally invasive cardiovascular surgical equipment company focused on EndoCABG, Howe managed all aspects of the business and coordinated phase 2 clinical trails. In 1998, Medical Dynamics was successfully sold to *Medtronic Corporation.

As the national director of Genzyme BioSurgical, an innovative minimally invasive surgery and bio science division, targeting the acute care market, Howe was instrumental in the coordination of phase three clinical trials for new biotech and medical devices. Howe was also responsible for the adjunct and follow-on sales of FDA approved products to IDN's and systems healthcare.

Howe was given his start out of undergraduate as a "Fast Track" Pharmaceutical Sale Representative for the Lilly & Dista Divisions of Eli Lilly. Howe worked his way up the corporate ladder by exceeding his numbers in territory sales while earning a EMBA. Howe was propelled into the Bio-pharma & Medical Device Divisions of Lilly IVAC, focusing on the economical improvement & disease management through minimally invasive surgery and bio-films. Howe oversaw five geographic sales districts targeting acute care operating rooms & surgery centers. Howe was instrumental in the launch, promotion, sales and distribution of three new prescription pharmaceuticals and 12 revolutionary surgical equipment offerings, and coordinated 33 independent efficacy/economic impact trials.